Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
1(33%)
Results Posted
0%(0 trials)
Terminated
1(33%)

Phase Distribution

Ph not_applicable
1
33%
Ph phase_4
1
33%
Ph phase_2
1
33%

Phase Distribution

0

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
Phase 4Post-market surveillance
1(33.3%)
N/ANon-phased studies
1(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Completed(1)
Terminated(1)

Detailed Status

Terminated1
Completed1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
50.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (33.3%)
Phase 41 (33.3%)
N/A1 (33.3%)

Trials by Status

terminated133%
completed133%
recruiting133%

Recent Activity

1 active trials
Showing 3 of 3
completedphase_4

A Comparative Study on the Efficacy of Blue Light Emitting Diodes Therapy Versus Targeted Narrow Band UVB in Stable Non-segmental Vitiligo Patients.

NCT07174024
recruitingphase_2

Vitiligo, New Treatment and Serum s100B

NCT06768840
terminatednot_applicable

Examination Of Vitiligo Skin Samples Before and After UVB Treatment

NCT00177034

Clinical Trials (3)

Showing 3 of 3 trials
NCT07174024Phase 4

A Comparative Study on the Efficacy of Blue Light Emitting Diodes Therapy Versus Targeted Narrow Band UVB in Stable Non-segmental Vitiligo Patients.

Completed
NCT06768840Phase 2

Vitiligo, New Treatment and Serum s100B

Recruiting
NCT00177034Not Applicable

Examination Of Vitiligo Skin Samples Before and After UVB Treatment

Terminated

All 3 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
3